Cardiac troponin I (cTnI) was measured by chemiluminescent immunoassay following burn injury. Thirty patients [total body surface area (TBSA) of burn 15-98%] were included in this study and each had four to six blood samples collected at 2-day intervals between the 5th and 14th days post-burn. All patients were found to have increased cTnI on two or more occasions. The mean cTnI
concentration was significantly higher in patients with TBSA of burn > 30% (0'34 jlg/L compared with 0·09 jlg/L, P<O·OOI) and in those with obvious burn wound exudation (O·32jlg/L compared with 0·12jlg/L, P<O·OI). cTnI concentrations peaked at the time when there was obvious burn wound exudation or spontaneous separation of eschar, then decreased after surgical excision. Two patients with persistently high cTnI concentrations developed tachycardia. We conclude that burned patients have varying degrees ofnon-ischaemic cardiac injury, manifesting as leakage of cTnI from myocytes into the circulation.
Thermal injury and sepsis initiate a systemic inflammatory cascade that causes multiple organ failure. t -3 Transient cardiac contractile dysfunction is believed to be a result of myocyte damage following thermal injury.v" These findings emphasize the need for a specific cardiac marker after burn injury. Creatine kinase (CK) and its MB isoenzyme (CK-MB) are recognized to be incompletely cardiac-specific.P Cardiac troponin I (cTnI) is a contractile protein exclusively present in cardiac muscle.v!' and elevation of serum cTnI concentration is only found in the presence of cardiac injury. [13] [14] [15] [16] The sensitivity of cTnI for ischaemic cardiac damage is similar to that of CK_MB,J6-18 and the specificity and sensitivity of cTnI in detecting non-ischaemic heart disease have been shown to be better than those of CK_MB. 3.J8-20 Further to our recent report that cTnI detected myocyte damage in acute heart failure (non-ischaemic cardiac damage not indicated by CK-MB),21 we carried out a prospective study to explore the possibility of using cTnI as a specific cardiac marker for burned patients. In our initial experiment, we found that some patients had trace amounts of Correspondence: Dr Yi Ni Chen. E-mail: stsxns@zsulink.zsu.edu.cn cTnI detected during the first 2 days post-burn, but cTnI appeared again at clinically significant concentrations from day 5 onward. This is the time period when patients are most likely to develop infection and sepsis. Accordingly, we postulated that cTnI release from myocytes might be related to sepsis and endotoxin release. We have evaluated the clinical significance of monitoring cTnI after burn injury.
MATERIALS AND METHODS

Patients
Thirty burned patients (I8 women, 12 men) admitted to Guang Zhou Red Cross Hospital during the period May 1998 to April 1999, were included in this study. None had a previous history of cardiac vascular disease. The patients' ages ranged from 2 to 60 years, and they had total body surface areas (TBSA) of burn between 15% and 98%. The delay between injury and admission was between 30 min and 4 h. After admission, patients were transfused with plasma or dextran using a standard resuscitation protocol, the Parkland formula." Eight patients were transferred from other medical centres to our hospital 3--4 days after the bum injury. These patients were treated with fluid resuscitation according to the same protocol, but none had excision and grafting performed before transfer. Excision and grafting were performed on all the patients in the study as soon as their clinical condition permitted. Some patients had more than one treatment. Electrocardiogram (ECG) monitoring and recording of bum wound appearance were carried out daily during the observation period. Patients were monitored for both systemic and bum wound infection.
Sample collection
The first blood sample was collected on day 5, with further samples at 2 day intervals between days 5 and 14 post-bum. Patients with obviously elevated cTnl concentrations had more frequent cTnl measurements.
Determination of cTnI concentration
All blood specimens were centrifuged within 2 h of collection. Serum cTnl was measured within 4 h of collection by the Access Chemiluminescent Immunoassay System (Beckman Instruments, Cheska MN, USA). The assay sensitivity stated by the manufacturer was 0·01 jJ,g/L, with a reportable range of 0·01-50jJ,g/L. 16 Total imprecision (coefficient of variation) across the assay range is < 7% [determined using Access Low and High QC samples (Beckman), one assay per day, two replicates per assay, 10 assays over a 6-week period]. The reference range used routinely in our laboratory is < 0·03 jJ,g/L, derived from measurements in 50 healthy volunteers.
Statistical analysis
Results were grouped according to burn area (TBSA < 30% or > 30%) and wound appearance (with/without exudation). The highest cTnl concentration reached in each patient was chosen for calculation of the mean concentration. Logarithmic transformation was applied to calculate the geometric mean and 95% confidence interval (CI). The Wilcoxon rank sum test was used to test the significance of differences in cTnI levels between groups.
RESULTS
All patients had increased cTnI concentrations on two or more occasions. The highest cTnI concentration from each patient was included in the statistical analysis (see Table I ). Patients with TBSA of burn > 30% had a geometric mean peak cTnI concentration of O' 34 jJ,g/L (95% CI: 0·25-0·46), significantly higher than that of the other patients (geometric mean peak Ann Clin Biochem 2000: 37 cTnI concentration 0·09 jJ,g/L; 95% CI: 0·06-0'14; P<O·OOI). Eighty per cent (16/20) of patients with TBSA of burn >30% and 33% (3/10) of patients with TBSA of burn <30% had bum wound exudation or infection. As expected, mean cTnI concentrations were significantly different between groups with differing bum wound appearance: patients with bum wound exudation had a geometric peak cTnI concentration of 0·32 jJ,g/L (95% CI: 0·22-0·48), while those without exudation had a geometric mean peak cTnI concentration of 0·12jJ,g/L (95% CI: 0.07-0,21; P<O·OI). ECG changes related to ischaemic heart disease were not detected in any patients during the observation period. Of the exudation group, II were found to have superficial infection of the bum; two died from invasive infection with bacteraemia (TBSA of bum 91% and 96%, respectively). Interestingly, seven of these patients were found to have fluctuating cTnl concentrations, with one or two peaks throughout the observation period and cTnI concentrations ranging from < 0·03 jJ,g/L to I·3 jJ,g/L, a concentration normally seen in patients with acute myocardial infarction (AMI). The time of peak cTnI concentration varied from patient to patient, ranging from day 7 to day 13. Increasing cTnI concentration was related to the patient's clinical condition. Peak cTnl concentrations were found when patients had obvious bum wound exudations/superficial infection or spontaneous separation of eschar, normally accompanied by a high temperature and a pulse between 130 and 160 per min. cTnl concentrations decreased 2 or 3 days after surgical excision and cardiac supportive agents. Two cases with persistently high cTnI concentrations had tachycardia, although there was no typical ECG evidence to suggest an AMI. One of these patients went into coma on day 9. The cTnI concentration-time curves of three typical patients are shown in Fig. I .
DISCUSSION
Previous studies have demonstrated that burn injury enhances systemic inflammatory response and results in cardiac injury.3.23 In animal models, cTnI reached a peak concentration at around 24 h after the bum, and cardiac contractile deficit paralleled the cTnI leveJ. 3, 23 We saw no evidence of this in our initial study of patients admitted to hospital within 4 h postburn and receiving proper fluid resuscitation. clinical evidence of AMI. This phenomenon has been reported in critically ill patients'<!? and in acute heart failure patients, who had elevated cTnI concentration with no ECG changes and normal CK-MB activity." It was suggested from these previous studies that circulating cTnI detected in the absence of AMI is a consequence of cardiac cell membrane damage promoted by increasing oxygen consumption and oxidative stress. 19.21 However, there may be other mechanisms involved in burn injuries. It is known that one major pathophysiological change post-burn is an acute inflammatory response initiated by infection, toxaemia and absorption of toxic material.P-" The inflammatory response promotes the release of many mediators, including tumour necrosis factor ex, interleukins, and oxygen-derived free radicals.P' Such mediators are known to cause cell membrane defects and tissue damage.':":" Troponin I exists in the myocyte both as protein-bound and functionally unbound forms. II It is believed that leakage of unbound cTnl from the cytosol pool could occur when cell membrane permeability increases. Considerable quantities of cTnI would be exposed to the extracellular environment if death of rnyocytes followed.x. 19.27 We found in this study that leakage of cTnl was more severe at the stage when toxaemia is most likely to occur specifically, severity of leakage paralleled the appearance of burn wound exudation. This seems to indicate that cTnI leakage is closely related to systemic response initiated by burn wound infection and exudation. When patients were monitored closely for changing cTnl patterns, we found that the peak cTnI concentration occurred during the time period when burn wound exudation/infection or spontaneous separation of eschar were noticed, and concentrations returned to normal a few However, one special case (98% burn) with obvious hypovolaemic shock on delayed admission (6 h after burn) had detectable cTnI as early as 10 h post-burn, and cTnI persisted at concentrations around 0·30-0·50/lg/L for a week, then climbed to a peak at day 9, when burn wound infection occurred. We speculate that proper fluid resuscitation in the early postburn period may prevent early myocyte damage.
In the samples collected between 5 and 14 days post-burn, half the patients had a cTnI concentration greater than 0'33/lg/L, a level normally found in AMI, but there was no days after excision of eschar. Disappearance of circulating cTnI soon after excisional therapy was observed in five cases. Three patients had to have two excision treatments and their cTnI concentrations remained high or increased further when the untreated burn wound appeared to have severe exudation or spontaneous separation of eschar. These findings seem to support the theory that early excision could prevent later development of organ failure.P The finding of increased circulating cTnI in post-burn patients raises the question of whether serial cTnI measurements could help patient management. Although most of the patients with transient increases of circulating cTnI did not develop severe cardiac dysfunction, two cases who had persistently high cTnI concentrations were later found to have tachycardia and one went into coma (see Fig. I , curve C). Another patient (see Fig. I, curve B ) who had hypovolaemic shock in the early stages was found to have persistently high cTnI concentrations. Such patients would benefit from serial cTnI monitoring and early treatment. Although the patients in this study had no previous history of cardiovascular disease, we speculate that patients with such a history would be vulnerable to cardiac damage, and cTnI monitoring would be important for them. Optimal treatment might seek to normalize cTnI and (equally important) to prevent toxic eschar material from gaining access to the circulation. L-arginine has been shown to protect the cardiac cell membrane and preserve cell membrane integrity. 15 Further studies should elucidate the effect of such preventative treatment on cTnI concentrations. 
